Core Scientific, Inc. CORZ Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 16.9%+4.3pp | 11.9%-11.8pp | 6.6%-21.3pp | 5.1%-24.6pp | 12.6%-17.6pp | |
| Operating margin | -144.7%-85.3pp | -78.4%-50.6pp | -58.7%-45.6pp | -51.6%-44.1pp | -59.5%-69.5pp | |
| EBITDA margin | -126.2%-92.0pp | -56.8%-51.1pp | -34.5%-42.7pp | -24.9%-37.1pp | -34.2%-63.0pp | |
| Free cash flow margin | -130%-88.3pp | -141.3%-131pp | -102.9%-98.1pp | -73.7%-73.9pp | -41.7%-45.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×-0.2× | 0.2×-0.3× | 0.2×-0.5× | 0.3×-0.5× | 0.3×-0.4× | |
| Liquidity | ||||||
| Current ratio | 0.5×-3.7× | 1.1×-5.6× | 1.6×-2.0× | 1.8×+0.2× | 4.3×+3.2× | |
| Quick ratio | 0.5×-3.7× | 1.1×-5.6× | 1.6×-2.0× | 1.8×+0.2× | 4.3×+3.2× | |
| Cash ratio | 0.4×-3.1× | 0.4×-5.8× | 0.7×-2.6× | 1×-0.3× | 3.6×+2.7× | |
| Leverage | ||||||
| Debt-to-assets | 0.7×0.0× | 0.5×-0.3× | 0.5×-0.2× | 0.6×-0.3× | 0.7×-0.1× | |
| Per Share | ||||||
| Book value per share | -$4.04-376% | -$3.03+17.9% | -$3.54-25.3% | -$3.35+49.4% | -$0.85+24.6% | |
| Valuation | ||||||
| Market capitalization | $4.72B+121% | $4.51B+15.1% | $5.51B+160% | $3.64B+120% | $2.14B+239% | |
| Enterprise value | $5.73B+119% | $5.37B+25.6% | $6.22B+158% | $4.22B+95.1% | $2.62B+127% | |
| Price / sales | 13.3×+8.1× | 14.2×+6.5× | 16.5×+12.7× | 10.4×+7.6× | 5.2×+4.1× | |
| EV / sales | 16.1×+9.8× | 16.8×+8.5× | 18.6×+14.3× | 12.1×+8.3× | 6.4×+4.3× | |
| Free cash flow yield | -9.8%-1.7pp | -10%-8.7pp | -6.2%-5.0pp | -7.1%-7.1pp | -8%-11.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Core Scientific, Inc.'s profit margins?
- Core Scientific, Inc. (CORZ) runs a 16.9% gross margin and a -144.7% operating margin, with a -238.9% net margin.
- Where do Core Scientific, Inc.'s ratios come from?
- Every ratio is computed from Core Scientific, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
